We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
- Authors
Crane, Christopher H; Winter, Kathryn; Regine, William F; Safran, Howard; Rich, Tyvin A; Curran, Walter; Wolff, Robert A; Willett, Christopher G
- Abstract
The primary objective of this study was to assess the 1-year survival of patients with locally advanced, unresectable pancreatic cancer treated with the combination of bevacizumab, capecitabine, and radiation. Secondary end points were toxicity, progression-free survival (PFS), and response rate (RR).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 25, p4096
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2009.21.8529